Salix Pharmaceuticals, Ltd.Morrisville, NC, United States (NASDAQ (GM): SLXP)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Salix Pharmaceuticals Financial Statements

Salix Pharmaceuticals Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Salix Pharmaceuticals Income Statement

  2007 2006 2005
Revenue ($ mil.) 235.8 208.5 154.9
Gross Profit ($ mil.) 180.8 167.1 120.6
Operating Income ($ mil.) 11.9 30.3 (61.1)
Total Net Income ($ mil.) 8.2 31.5 (60.6)
Diluted EPS (Net Income) 0.17 0.65 (1.55)
More Salix Pharmaceuticals financial information

Salix Pharmaceuticals Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 41.1 34.3 39.5
Gross Profit ($ mil.) 33.8 25.5 22.6
Operating Income ($ mil.) (6.7) (23.9) (17.4)
Total Net Income ($ mil.) (7.1) (24.0) (19.0)
Diluted EPS (Net Income) (0.15) (0.50) (0.39)
More Salix Pharmaceuticals financial information

Salix Pharmaceuticals Stock Quote & Chart

12/02/08 16:00:01 EST • NASDAQ • 7.55 • Increased by +0.3200 • Increased by +4.4260 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Salix Pharmaceuticals Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 2.31 3.14 1.38
Price/Earnings Ratio -- 13.59 14.44
Price/Book Ratio 1.60 2.53 1.34
Price/Cash Flow Ratio 9.01 11.92 8.71
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Salix Pharmaceuticals Financial Ratios

Salix Pharmaceuticals Competitive Intelligence

GlaxoSmithKline Pfizer Procter & Gamble
Annual Sales ($ mil.) 22,716.0 48,418.0 83,503.0
Employees 103,401 86,600 --
Market Cap ($ mil.) -- 115,742.9 218,780.2

Competitive Landscape